Ametros is the industry leader in post-settlement medical administration and a trusted partner for thousands of members receiving funds from workers’ compensation and liability settlements. Founded in 2010, Ametros provides post-settlement medical management services with significant medical and pharmacy discounts along with automated payment technology and Medicare reporting tools. Their depth of expertise in the MSA, property and casualty insurance, healthcare, legal, financial and software industries positions them to offer the best product in the marketplace. Ametros is backed by Clarion Capital Partners, LLC, a New York based private equity firm. Headquartered just north of Boston in Wilmington, Massachusetts, Ametros may be reached at 877.275.7415 or via www.ametroscards.com
Primary Industry:
N/A
Ametros is the industry leader in post-settlement medical administration and a trusted partner for thousands of members receiving funds from workers’ compensation and liability settlements. Founded in 2010, Ametros provides post-settlement medical management services with significant medical and pharmacy discounts along with automated payment technology and Medicare reporting tools. Their depth of expertise in the MSA, property and casualty insurance, healthcare, legal, financial and software industries positions them to offer the best product in the marketplace. Ametros is backed by Clarion Capital Partners, LLC, a New York based private equity firm. Headquartered just north of Boston in Wilmington, Massachusetts, Ametros may be reached at 877.275.7415 or via www.ametroscards.com
Transparency
All reviews within the past 12 months
Total Reviews
0
Direct
0
Invited
0
Write a review ✍🏼
Leave your review here
No reviews yet
Be the first one to write a review 🎉
Traffic & Engagementbad
Verification on TrustFinanceUnverified
Consumer
0
The number of user on TrustFinance
Provided by TrustFinance
We use cookies
Our website uses cookies to improve your browsing experience and to help us understand how users interact with our site. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.
